Media Contact

Join leading experts in #neuroscience and clinical development as they discuss how #biomarkers are transforming trials in Alzheimer’s, Parkinson’s, and related neurodegenerative diseases. This session will cover: - Inte...

Biomarkers are redefining clinical trial success in neurodegenerative diseases. Join us for a focused webinar on how imaging, wet, genetic, and digital biomarkers are improving trial accuracy, patient selection, and end...

We’re looking forward to participating in and hosting C-Path's annual eCOA Consortium EU meeting on October 8–9 at ICON’s Dublin office. This meeting brings together leading eCOA experts to address key industry challen...

LabView360 is ICON’s new digital requisitioning application that streamlines end-to-end sample management—eliminating paper requisition forms, reducing errors, and saving valuable time for sites and sponsors. With digi...

#RAPSConvergence 2025 is less than a week away! Join ICON in Pittsburgh, 7 - 9 October, for the largest annual event dedicated to regulatory affairs. At booth 409, our team will showcase how we can facilitate end-to-end...

A recent peer-reviewed study co-authored by Tim Clark, VP Clinical Sciences at ICON, reviewed UK HRA submissions to evaluate how estimands are being defined post-ICH E9(R1). Findings show that while usage has increased,...

Integrating modern technologies and scientific advances into cardiovascular outcomes trials can streamline their execution and improve efficiency. Find an overview of tools and strategic approaches sponsors can use to ma...

In this latest thought leadership article on biosimilar drug development, the head of ICON’s Centre for Biosimilar Drug Development outlines what the next era of biosimilars will look like. As the patent cliff approach...

Our Talent Acquisition team recently took part in the University of Buenos Aires Career Fair at the Faculty of Pharmacy and Biochemistry. It was a great opportunity to connect with students and future professionals, shar...

Accelerating enrollment through smarter access. Explore how ICON’s extensive patient access network and tailored recruitment strategies helped a sponsor meet enrollment goals faster and more efficiently. https://ow.ly/wV...

Visit the ICON team at #ACR25, booth 1501 to discover how our strategic solutions and innovative methods help reduce patient burden, meet enrolment targets, and accelerate access to new treatment options for autoimmune d...

Systemic autoimmune rheumatic diseases are rising globally. Speak with ICON experts at #ACR25, booth \#1501 to learn how our deep experience delivering rheumatology studies helps sponsors to advance autoimmune therapie...